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Abstract 
Using ethylene glycol (EG) and vitamin D3 as crys-
tal-inducing diet (CID) in rats, we investigated the effect 
of the dosage of EG on the generation of chronic calci-
um oxalate (CaOx) nephrolithiasis. We collected weekly 
24 hour urines and measured herein the amount of ox-
alate, calcium, glycosaminoglycans (GAG's), creatinine, 
protein, alkaline phosphatase (AP), "(-glutamyl transpep-
tidase ("(-GT), and N-acetyl-13-glucosaminidase (NAG). 
The potential of these urines to inhibit crystal growth 
and agglomeration was also evaluated. After four 
weeks, the kidneys were screened by histology and 
radiography for the presence of CaOx crystals and the 
amount of kidney-associated oxalate was biochemically 
measured. Using 0.5 vol.% EG, only a part of the rats 
showed CaOx deposition in the renal cortex and/or me-
dulla, without obvious differences between Wistar and 
Sprague-Dawley (SD) rats. If a dietary EG concentra-
tion of 0. 75, 1.0. or 1.5 vol.% was used, the amount of 
kidney-associated oxalate was proportionally higher and 
CaOx crystal formation was consistently found in all 
rats. Most crystals were encountered in the cortex, 
whereas in the medulla and the papillary region, crystals 
were only occasionally detected. From these data, we 
conclude that in the chronic rat model, based on EG and 
vitamin D3 , a consistent deposition of CaOx crystals is 
obtained using a EG concentration of at least 0. 75 % . 
Key Words: Calcium oxalate, urolithiasis, rat model, 
vitamin D, ethylene glycol, Tamm-Horsfall protein, 
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Introduction 
Hyperoxaluria is a major risk factor in calcium ox-
alate (CaOx) stone disease. Apart from the so-called 
"idiopathic" stone forming patients, in which stone for-
mation is attributed to diurnal and seasonal variations in 
oxalate absorption [17), hyperoxalurias mainly occur in 
patients with inborn errors of metabolism [14). Such 
patients have recurrent CaOx stones that lead to progres-
sive renal failure and death at an early age. 
Several animal models have been proposed to extend 
the understanding of the etiology of human stone dis~se 
[3, 23, 34, 41). In rats, hyperoxaluria can easily be in-
duced by various diets. Most of these diets are based on 
increasing the oxalate production by administration of 
oxalate precursors such as ethylene glycol (EG) [3, 23). 
Moreover, in the rat kidney, the physiology and distribu-
tion of oxalate among cortex, medulla, and papilla, is 
reported to be similar to that in the human kidney [19) . 
For studies on experimental nephrolithiasis, two 
types of rat models are currently available [23) : acute 
and chronic models. In the acute models, animals are 
challenged with a relatively large dose of lithogen and 
the urinary oxalate load is increased within minutes (21, 
25). Brigman and Finlayson [1] used a single intraperi-
toneal injection of sodium oxalate to test the efficiency 
of various drugs in reducing the precipitation of intratu-
bular CaOx salts within the renal tubules . Although in 
the acute models, induced hyperoxaluria is followed by 
crystalluria and formation of CaOx crystals within the 
renal tubules and the interstitium, renal stones are not 
formed . In the chronic models, rats are continuously 
challenged with smaller doses of lithogen for a longer 
period, up to 30 days (2, 9, 10, 11, 19). In this model, 
the CaOx crystals formed are retained long enough with-
in the tubular system to be deposited in the interstitium. 
Several chronic models are available. Buck et al. 
(2) used daily injections of calcium gluconate to intro-
duce nephrocalcinosis . In the present study, we focused 
our attention on the chronic vitamin D3/EG model. This 
model, originally described by Okada et al. (32] and 
modified later by Reis-Santos et al. (35), is based on the 
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formation of intratubular CaOx crystals as a result of the 
supersaturation, generated by the vitamin Drinduced en-
hancement of urinary calcium concentrations and EG-in-
duced hyperoxaluria [33). In order to further character-
ize the model, and to define the conditions consistently 
leading to CaOx deposition in the rat kidneys , we inves-
tigated the following parameters: (1) The urinary ex-
cretion and renal deposition of CaOx at successive points 
of time of feeding the vitamin D3 and 0.5 % EG . (2) 
At that point of time at which, with 0.5 % EG , most 
renal crystals were encountered, the effect of increasing 
EG-concentrations on the renal deposition of Ca Ox crys-
tals. In addition, the urinary excretion of glycosa-
minoglycans (GAG's) and the urinary inhibitory activi-
ties of crystal growth and agglomeration were investi-
gated. Possible kidney damage was assessed by follow-
ing the urinary excretion of creatinine and the release of 
protein and renal enzymes into the urine. 
Materials and Methods 
Thirty-three male Wistar and Sprague Dawley (SD) 
rats weighing 250-300 g were obtained from the Central 
Animal Breeding Centre (Harlan, Zeist, The Nether-
lands). After arrival , the rats were acclimatized for 
seven days . All rats had free access to 40 ml drinking 
water every day. Mild chronic hyperoxaluria was in-
duced by EG and vitamin D3 (Sigma, St. Louis, MO, 
USA). EG was supplemented to drinking water to a fi-
nal concentration of 0.5 vol.% or higher. Vitamin D3 
was di ssolved in cottonseed oil (Sigma) at a concentra-
tion of one µg lml , of which, compulsorily , 0.5 ml was 
orally administrated by stomach intubation every other 
day. Control rats did not receive vitamin D3 and EG 
had been omitted from their drinking water. All rats 
received a standard rat chow (Diet AM II , Hope Farms, 
Woerden, the Netherlands), consisting of (in weight % , 
wt. % ) : rough protein (23. 3 % ) , fat ( 6 .4 % ) , rough cell 
compound (3 .2%), rough ash (4.4%), and a salt mix-
ture, containing phosphorus (0.48 % ), magnesium 
(0. 12 %), sodium (0.24%), and potassium (0.8%). The 
calcium content varied per batch between 0.56-0.83 % 
(mean: 0.70%) . 
Urines were collected at the following points in 
time, for each animal separately. For the first experi-
ment, in which vitamin D3 + 0.5 % EG was used as 
crystal-inducing diet (CID), these urines were collected 
at days 0, 7 , 14, 21, 28 and 42. The animals were sac-
rificed at the indicated points in time (Table 1) . For the 
second experiment, in which vitamin D3 and three in-
creasing EG concentrations were used as CID, viz., 
0.75% (group I), 1.0 % (group II) and 1.5 % (group III), 
the urines were collected at days 0, 6, 9 , 14, 20 and 28. 
Each group consisted of three animals. The rats were 
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Table 1. Wistar and SD rats used for the CID experi-
ment of vitamin D3 + 0.5% EG. At the indicated 
points of time the urines were collected and the animals 
sacrificed. (SD Sprague Dawley rat). 
Rat number Day of Day of 
Wistar/SD Diet urine collection sacrifice 
1 + 2 standard 0 ,7, 14,21,28,42 42 
3 + 4 CID 0 , and 7 7 
5 + 6 CID 14 14 
7 + 8 CID 21 21 
9 + 10 CID 28 28 
11 + 12 CID 42 42 
individually kept in metabolic c.:ages and the urines were 
collected on ice without any preservative during 24 
hours. The volume and the pH of each urine were 
measured. This pH was between 6 .0 and 8.5. To one 
ml urine samples, 6 µI concentrated HCI was added and 
they were then analyzed for oxalate, calcium, magnesi-
um, and phosphate. The remaining unacidified urine 
was centrifuged at 1000 x g for 10 minutes and the ob-
tained supernatant was analyzed for creatinine, protein , 
alkaline phosphatase (AP), -y-glutamyl transpeptidase 
(-yGT) and N-acetyl-B-glucosaminidase (NAG). For all 
analyses, including the ions, Merck kits (Merck Diag-
nostica, Darmstadt, Germany), adapted to an Eppendorf-
Merck ELAN autoanalyser, were used. These assays 
were performed as prescribed by the manufacturer. The 
oxalate assays were performed with an enzymatic kit 
from Sigma, which is based on the oxidation of oxalate 
to CO2. The resulting H20 2 was measured by the for-
mation of a blue indam.ine dye, with a maximum absorp-
tion at 590 nm. For each oxalate assay, 0.5 ml urine 
was mixed with an equal vo lume sample buffer (final pH 
5.0-7.0). Of thi s mixture, 0.5 ml was pipetted in an 
Eppendorf tube, thoroughly mixed with 50 mg active 
carbon, and centrifuged at 10,000 rpm in a microcentri-
fuge for 2 minutes. Of the supernatant, 90 µI was used 
for the oxalate assay with autoanalyser. Using the oxa-
late standards of the test kit, the detection limit was 0.08 
µmo! oxalate/ml urine. Urinary GAG's were measured 
using 1,9-dimethylene blue as substrate [12). Urinary 
inhibitory activity was assessed by measuring the poten-
tial of the collected urines to inhibit growth and aggrega-
tion of CaOx seed crystals in a metastable solution [39). 
The pellets of the centrifuged unacidified urines (see 
above) were analyzed for the presence of CaOx crystals 
by Fourier-transform infrared spectroscopy (FTIR) [8] . 
For this purpose, the pell ets were washed by resuspen-
sion in water, followed by centrifugation at 3000 rpm, 
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Table 2. Calcium and oxalate excretion of Wistar and SD rats fed the standard chow and rats fed a CID of vitamin 
D3 and 0.5 % EG for the indicated points of time. At day O also all CID-fed rats were fed the standard chow. All Data 
are expressed as µmol/24 h. The data of the Wistar rats are also shown in Figure 1 (lA: calcium; and lB: oxalate). 
Rat Rat Experimental day 
Type Number Diet 0 7 14 21 28 42 Mean± s.d.* 
Calcium excretion 
Wistar 1 standard 17.o· 7.3 .. 17.8 .. 15.9 .. 29.2 .. 26.3 .. ) 17.6 ± 8.o· 
Wistar 2 standard 7.7 .. 15.8 .. 23_0· 12_5• 33_0· 20_5•) 
Wistar 3-7 CID 8.9 .. 0.6 6.4 10.6 8.9 25.3 
Wistar 6-12 CID 11.9• 9.3 11.3 4.6 4.3 11.4 
SD 1 standard 11.7V 20.2V 19.8v 11.lV 32.3v 10.4V) 19.3 ± 9.4V 
SD 2 standard 8.3v 28.2V 26.0v 8.7v 39. lV 15.4V) 
SD 3-7 CID 18.3v 4.8 9.7 2.2 14.4 1.2 
SD 6-12 CID 20.7v 8.0 9.5 8.9 10.0 5.8 
Oxalate excretion 
Wistar 1 standard 9.9 .. 10.5 .. 13.2 .. 8.2· 4.8 .. 9. 1 • ) 8.8 ± 2.0· 
Wistar 2 standard 6.4 .. 9 .1 .. 7.4• 10.2· 10.5 .. 8.6 .. ) 
Wistar 3-7 CID 8.1 .. 8.9 98.0 54.3 57 .6 36.6 
Wistar 8-12 CID 7.8 .. 37.6 62.4 12.0 33.6 29.8 
SD 1 standard 3.7V 9_3V 9.9V 15.6v 8.9v 7.8v) 9.1 ± 3.9V 
SD 2 standard 4.3V 8. lV 8.9v 16.2v 9.0v 14.4V) 
SD 3-7 CID 6.5v 41.1 18.3 85.1 81. 7 12.2 
SD 8-12 CID 5.2v 15.5 45.6 86.6 34.1 17.3 
*Pooled data of all Wistar rats (*) and SD rats (v) fed the standard chow (for 0, 7, 14, 21, 28, and 42 days) . 
dried and pulverized. The crushed crystals were mixed 
with 200 mg KBr and analyzed with a Biorad FTS-7 
(Veenendaal, The Netherlands). 
At 28 days, the rats were anaesthetized with diethyl-
ether, followed by an intramuscular injection with a 12 
wt.% solution of urethane (Fluka, Buchs, Switzerland) 
in physiological saline at a dose of 1 ml per 100 g body 
weight. The kidneys were perfused through the abdomi-
nal aorta with physiological saline. Small pieces of the 
cortex and medulla of the right kidneys were excised, 
fixed with 4 % paraformaldehyde and embedded in paraf-
fin. The tissue sections were stained with haematoxy-
lin/eosin (HE) and examined by light microscopy. 
The right and left kidneys were weighed and 
scanned by radiography for the presence of CaOx crys-
tals. The right kidneys were homogenized as follows : 
the cortical/medullary- and the papillary part were di-
gested in 6 ml, respectively, 1 ml digestion buffer, 
consisting of 10 mmol Tris-HCl (pH 8.0), sodium do-
decyl sulphate (SDS; 1 wt.%) and proteinase K (0.14 
mg/ml) (Glenny RW, personal cornnrnnication, 1993). 
The left kidneys were entirely homogenized in 7 ml 
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digestion buffer. The digestions were performed for 24 
hours in a water bath at 45-50°C. The suspensions were 
centrifuged for 10 minutes at 1000 x g. The pellet with 
the crystals was dissolved in 0.3 N HNO3 and the 
amount of oxalate was measured in the pellet and super-
natant as described above. All data were expressed as 
µmo! oxalate per kidney and statistically analyzed by 
Kruskal-Wallis 1-way ANOV A tests . 
The urinary data are presented as mean ± standard 
deviation (s .d.). Since the number of data was too low 
to assume a normal distribution, non-parametrical tests 
were used for the statistical analyses: (1) for the detec-
tion, for each point in time, possible differences between 
the CID-fed rats and the rats fed the standard diet (day 
0) Wilcoxon matched-pairs tests were used. The reason 
for this approach was that both populations were formed 
by the same rats. In these analyses, the data of group 
I-III were pooled for each point in time and compared 
with the data of the rats fed the standard diet (day 0). 
Significant differences (p < 0.05) are indicated in the 
various figures (*) . (2) For the detection, for each 
point in time, of differences between the three groups 
R. de Water et al. 
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Figure 1. Urinary excretion of calcium and oxalate in 
control (open bars; mean ± s.d. ; n = 4) and CID-fed 
animals at the indicated points of time (hatched bars; 
presented as data of individual rats). (A) Calcium 
excretion; (B) Oxalate excretion. 
Kruskal-Wallis 1-way ANOV A tests were used. The ex-
istence of significant heterogeneity (p < 0.05) between 
these group is indicated in the various figures (0 •). (3) 
To detect, for each urinary parameter, significant (p < 
0.05) time-related changes, Friedman two-way ANOV A 
tests were used. 
Results 
Time course study 
In initial experiments with Wistar rats, we adminis-
tered a CID of vitamin D3 and 0.5 % EG and examined 
the urinary excretion and renal deposition of calcium and 
oxalate. In addition, the composition of the excreted 
urinary crystals was determined. The results are pre-
sented below as data of individual rats and compared 
with rats fed only the standard chow (control rats). 
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Kidney-associated oxalate 
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Figure 2. Oxalate content in kidneys of control and 
CID-fed animals. The cortical/medullary regions are in-
dicated with the hatched areas and the papillary regions 
with the solid areas. The results are presented as data 
of individual rats. 
Since it has been reported that after phosphorus- and 
vitamin B6 deprivation, SD rats have a higher urinary 
oxalate excretion than Wistar rats [45], we performed, 
using the CID of vitamin D3 and 0.5 % EG, a duplicate 
experiment with SD rats. 
Urinary excretion of calcium and oxalate: In con-
trol rats, the urinary calcium excretion varied between 
10-30 µmol per 24 hours. During the first three weeks 
of CID, all rats showed a reduced urinary calcium ex-
cretion, although this decrease was less pronounced at 
28 and 42 days (Fig. IA, Table 2). The oxalate excre-
tion increased considerably after CID, but also varied 
between the individual animals (Fig. lB, Table 2). 
Maximal values were obtained at 14, 21, and 28 days. 
The urinary calcium/oxalate ratio was 2.2 ± 1.5 in 
control rats, whereas in CID-fed rats, this ratio was 
always lower than 0.4. 
Kidney-associated oxalate: The kidneys of control 
rats contained approximately 0.4 µmol oxalate. During 
the first three weeks of CID the amount of oxalate was 
slightly increased. Considerably higher values were ob-
served at 28 and 42 days, with a wide variation between 
the individual animals (range: 0. 8-7 .9 µmol, respec-
tively, 1.0-9.0 µmo!) . Of the total kidney-associated 
oxalate ranging 0.06-1.6 µmol, maximally 0.04-0.9 
µmo! oxalate, respectively, was associated with the pa-
pilla at these points of time (Fig. 2). 
Analyses of urinary crystals: The urinary crystals 
of the control rats consisted predominantly of phosphate 
with calcium or magnesium (apatite and struvite). CaOx 
monohydrate crystals (whewellite) were encountered, but 
Experimental rat nephrolithiasis 
Calcium excretion 
µmol/24 h 
30~-----------------~ 
25 
20 
15 
pmol/24 h 
* 
CID (days) 
Oxalate excretion 
A 
* 
* 
200~------------------
B 
* * 
CID (days) 
~ 0.75% EG + vii. D ~ 1.0 % EG + vit D ■ 1.5% EG + vit D 
Figure 3. The effect of the concentration of dietary EG 
on the urinary excretion of calcium and oxalate. Each 
bar represents the mean (± s.d.) of nine animals (open 
bars; controls) or three animals (hatched bars; CID-fed 
animals). Significant differences with the control rats 
are indicated(*). The EG concentration in the drinking 
water is displayed in the box at the bottom of Figure 3. 
(A) Calcium excretion; (B) Oxalate excretion. 
only in low percentages(~ 5%). During the first three 
weeks of the CID, whewellite crystals were slightly 
more often found (2-10%), but most frequently at both 
28 and 42 days (2-50 % ). CaOx dihydrate crystals (wed-
dellite) were only observed at day 42 (0-20 % ). 
Effect of the EG concentration in the CID 
In a previous study [13], we found that a CID of 
vitamin D3 and 0.5 % EG lead in only eight (53 % ) of the 
fifteen CID-fed animals to renal deposition of CaOx 
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Figure 4. The effect of the concentration of dietary EG 
on the oxalate content of (1) the total kidney, (2) the 
cortex/medulla, and (3) the papilla. The animals were 
fed the CID of EG and vitamin D3 for 28 days. Each 
bar represents the mean of three animals(± s.d.). Mu-
tual differences between the three groups in oxalate dep-
osition are indicated('"'"'"; p < 0.06). The EG concen-
tration in the drinking water is displayed similar to that 
in Figure 3. 
crystals. In this study, we investigated whether in-
creasing the EG concentration in the drinking water to 
0.75% (group I), 1.0% (group II), and 1.5% (group 
III), respectively, achieved a consistent deposition of 
renal crystals. The results of this study, in which we 
also followed the various urinary parameters, are pres-
ented below. 
Urinary excretion of calcium and oxalate: Com-
pared to the control animals, the excretion of calcium 
was reduced at all points of time after CID (p < 0.05), 
without differences between the three groups (Fig. 3A). 
The oxalate excretion had increased considerably after 
CID (p < 0.008), without differences between the 
groups, and without observable changes with time (Fig. 
3B). The calcium/oxalate ratio was 2.6 ± 1.6 in 
control animals (n = 6), whereas in group II and III this 
ratio was always lower than 0.4. No changes were 
observed in magnesium and phosphate excretion. 
Kidney-associated oxalate: In group I, the amount 
of oxalate in the total kidney was 17.8 ± 12.2 µmo!, of 
which 1.0 ± 0.6 µmol was associated with the papilla. 
In the cortex and medulla, the amount of oxalate was 
higher in group II and III, but not yet significant (p = 
0.06). The quantity of oxalate in the papilla remained 
at the same low level (Fig. 4) . Histological examina-
tions and evaluation of the radiographs showed that all 
kidneys had small crystals. These crystals were present 
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40.0 ± 5.5%, respectively. Both activities were re-
duced after CID (p < 0.03, p < 0.02, respectively). 
Only at day 9, the IA was dependent of the EG concen-
tration (Figs. 6A and 6B; p = 0.05 with the Kruskal-
Wallis test). A time-dependency was observed for the 
IG, probably caused by the relatively high values at 14, 
20, and 28 days (p < 0.03). 
Excretion of creatinine, protein and enzymes: 
Compared with control rats, the excretion of creatinine 
and NAG was roughly 20-30% reduced after CID (Figs. 
7 A and 7C). This decrease was not significant. Signifi-
cantly lower values were found for the release of protein 
at day 9, 14, and 20 (p < 0.04; Fig. 7B) and AP at day 
9, 14, and 24 (p < 0.05; Fig. 7D). Compared with the 
control rats, the activity of -y-GT was significantly 
reduced at day 6, 14, 20, and 28 (p < 0.05). The ex-
creted amount of -y-GT was related with time (p < 
0.04) and, at day 9, 20, and 28, also related to the 
amount of EG in the CID (p < 0.05; Fig. 7E). 
Analyses of urinary crystals: The urinary crystals 
of the control rats consisted predominantly of phosphate 
with calcium or magnesium (apatite and struvite). CaOx 
monohydrate crystals (whewellite) were encountered, but 
only in low percentages (:::;; 5 % ). During the first three 
weeks of the CID, whewellite crystals were found slight-
ly more often (2-10 % ), but most frequently at both 28 
and 42 days (2-50%). CaOx dihydrate crystals (weddel-
lite) were only observed at day 42 (0-20%). 
Discussion 
For generation of CaOx crystals in the rat kidney, 
several diets have been described. It has been reported 
that after phosphorus and vitamin B6 deprivation, SD 
rats show a stronger CaOx response than Wistar rats 
[45]. Using EG and vitamin D3 as CID, we could not 
confirm this finding. Khan et al. [22] found that adm.in-
istration of 0. 75 % EG through drinking water for 24 
days did not result in a consistent renal deposition of 
crystals. The fact that we found, in our experiments 
with this EG concentration, a consistent renal crystal re-
tention, might be related to the additional administration 
of vitamin D3. 
The present results of the oxalate assays on the kid-
ney homogenates and the collected urines confirm earlier 
observations [23] that for crystal formation in rat kid-
ney , a severe hyperoxaluria is required. A prominent 
renal crystal retention occurred only in those animals 
with a daily oxalate excretion of 80-100 µmol. Assum-
ing a production of 30 ml urine per day , this value cor-
responds with a urinary oxalate concentration higher 
than 3 µmol/ml. In stone-forming patients, the urinary 
oxalate concentration is much lower. In healthy adults, 
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it is about 0.25 µmol/ml. In idiopathic stone formers, 
the urinary oxalate concentration lies between 0 .25-0.40 
µmol/ml, and in hyperoxaluric patients, between 0.4-0.8 
µmol/ml [7]. In vitro studies have shown that in human 
urine, crystal formation rises if urinary oxalate concen-
tration exceeds about 0.4 µmol/ml [17]. 
The rat differs from man in the low incidence of 
renal stones instead of crystals and the occurrence of 
crystals within the cortex rather than the medulla [15 , 
29]. In addition, vitamin D3-induced nephrocalcinosis 
involves the early parts of the proximal tubule located in 
the superficial cortex [3]. These data agree with the re-
sults of the present study. Examination of the radio-
graphs showed that crystal deposition in the renal papilla 
only increased at EG concentrations of 1.0 % and higher. 
Our biochemical analyses showed that the increase of 
oxalate associated with the papilla was low, compared to 
the large increase in the total kidney. 
Calcium oxalate crystals have also been experimen-
tally induced in the kidneys of non-human primates, but 
the required EG dose (15 mg/kg) is much lower than 
that for rats [36]. In our experiments, the optimum con-
centration of EG in drinking water was about 0. 75-1 % , 
which corresponds to a daily dose of 750-1000 mg/kg. 
This is, however, far below the LD50 (the amount of a 
substance that would be required to kill, within a speci-
fied time period, 50 % of the individuals in a large popu-
lation of animals or organisms) for rats of 4700 mg/kg 
after oral adm.inistration [40]. Chronic administration of 
EG at concentrations higher than l % may, however, 
cause toxic symptoms, such as nephrotoxicity and/or 
generalized metabolic acidosis and early death [20]. 
Although calcium and oxalate may both promote 
crystalluria and renal crystal formation, there are a num-
ber of indications that in humans, at calcium/oxalate 
ratio's larger than one, an increase in urinary oxalate 
concentration has a greater effect on the formation of 
CaOx crystals than comparable changes in urinary calci-
um [37, 38, 43]. It is indisputable that between healthy 
individuals and idiopathic stone formers, there are rela-
tively small differences in urinary oxalate concentrations 
(usually less than 0.1 µmol/ml). Other evidence for an 
important role for oxalate comes from clinical studies. 
Also, particle size measurements in urines of recurrent 
stone formers showed that the volume of CaOx crystals 
is related to the urinary oxalate and not to the urinary 
calcium concentration [38]. 
In the present study, we that the excretion of cal-
cium was lower in CID-fed than in control rats. In the 
control rats, the calcium/oxalate ratio was 2.6 ± 1.6, 
whereas, after CID of vitamin D3 and EG, this ratio was 
always lower than 0.4. This indicates that in hyperoxal-
uric rats, the urinary calcium concentration is the rate-
limiting step for the formation of CaOx crystals. The 
R. de Water et al. 
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Figure 7. The effect of the concentration of dietary EG 
on the urinary excretion of creatinine (A) , protein (B), 
and the renal enzymes NAG (C), AP (D), and -y-GT 
(E) . Significant differences with the control (*) group 
and within the three CID groups (•••) are indicated. 
The excretion of NAG and -y-GT changes with time (p 
< 0.05). The EG concentration in the drinking water 
is displayed conform the legend of Figure 3. 
fact that the calcium excretion in these rats was lower 
than in the control rats remains unexplained. This may 
be related to a reduced daily food consumption, since 
during CID diet, we observed a significant decrease in 
body weight in all animals, especially when the higher 
EG concentrations of 1.0 and 1.5% were used. 
Crystal formation is considered to be the result of 
an imbalance between supersaturation and the presence 
of crystallization promoters on the one hand and inhibi-
tor activity on the other [44] . In urine, a number of 
macromolecular inhibitors are present, among which 
GAG's, nephrocalcin and Tamm-Horsfall protein have 
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been investigated most extensively [4, 5, 6, 44]. Osteo-
pontin is, quantitatively, another macromolecular inhibi-
tor in urine. It is present in the epithelial cells of the 
thin descending loop of Henle and in the papillary sur-
face epithelium [28]. The synthesis of this glycoprotein 
is increased by vitamin D3 and the control element has 
been found in the promoter region of the osteopontin 
Experimental rat nephrolithiasis 
gene [30]. If, after a CID of vitamin D3 and EG, the 
synthesis of osteopontin is increased, a rise in inhibitor 
activity would be expected. If osteopontin is an inhi-
bitor of crystal agglomeration, then, this is evident on 
day 9 (Fig. 6B). However, the question of which inhibi-
tors contribute to the observed reduced urinary inhibito-
ry activity after CID deserves further attention, e.g., by 
measuring the urinary concentration of individual 
GAG's, osteopontin, Tamm-Horsfall protein, nephrocal-
cin and citrate. 
In the present study, the CID induced evidently not 
only severe hyperoxaluria, but it also reduced the poten-
tial of the urines to inhibit crystal growth and agglomer-
ation. In addition, there can be a lower production of 
urinary inhibitors; the observed reduction may have been 
due to co-precipitation of the inhibitor with CaOx crys-
tals. During growth and agglomeration, these crystals 
can bind macromolecular inhibitors and the absorbed 
layer has been visualized by light- and electron-micros-
copy [13, 26]. Another explanation for the observed re-
duction in urinary inhibitory activity may be that, in our 
hyperoxaluric rat urines, less ionic calcium is available. 
Most inhibitors require free calcium for crystal binding 
[18). 
It is known that hyperoxaluria with renal CaOx dep-
osition is harmful to the tubular epithelium. Several 
studies have shown that oxalate ions and CaOx crystals 
enhance the release of the renal enzymes AP, 1-GT, and 
NAG [16, 24, 27). In the present study, however, the 
release of protein and renal enzymes was reduced within 
seven days after a CID of 0. 75 % EG and vitamin D3. 
For r-GT, this reduction was even more pronounced, if 
the higher EG concentrations of 1.0 and 1.5% were 
used. Stonard et al. [ 42) also failed to find an increase 
in either NAG, AP, or protein in rats with nephrocal-
cinosis. Nouwen et al. [31), after injury of the renal 
epithelial cells, found a temporary loss in the expression 
of epidermal growth factor, Tamm-Horsfall protein , 
transferrin receptor and in lectin binding. From these 
considerations, it can be concluded that a CID of vita-
min D3 and EG in all likelihood induces renal damage. 
This damage may result in a decreased protein-synthesis 
and a lower release of proteins and renal enzymes at 
later points of time. In addition, it is conceivable that 
the urinary enzymes and other urinary glycoproteins ab-
sorb to the CaOx crystals during aggregation and ag-
glomeration, and coprecipitate during renal deposition. 
Both processes can occur at the same time. 
From the above considerations, we conclude that a 
CID of vitamin D3 and 0.5 % EG gives rise to crystal-
luria and a highly variable crystal deposition in the renal 
cortex. A higher EG concentration of 1.0, respectively, 
1.5 % , results in a proportionally higher crystal deposi-
tion in the cortex, whereas in the papilla, it remains at 
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the same level and induces renal damage. We conclude 
that for a consistent deposition of CaOx crystal, an EG 
concentration of 0. 75 % is required. 
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Discussion with Reviewers 
R.L. Hackett: In Figures 6A and 6B, you illustrate 
crystal growth and agglomeration inhibition. Although 
apparently not statistically different , there appears to be 
a trend that growth is inhibited less than agglomeration, 
especially in the 1.5 % EG and vitamin D3 group at ear-
lier time periods. Could you provide an explanation for 
this phenomenon? 
Authors: According to Ryall ' s group [39, 46), the 
Coulter Counter model has been used to characterize 
calcium oxalate monohydrate (COM) seeded crystal 
growth and agglomeration in the absence and presence 
of the rat urine. It is well known that crystal growth 
and agglomeration are different physico-chemical proc-
esses with different mechanisms, but they occur simul-
taneously in the test system used. The crystal growth 
and agglomeration can be independently evaluated based 
on changes in the total particle numbers and volumes 
measured by the Coulter Counter. This trend reflects 
two possibilities: (1) The components (inhibitors/promo-
ters) in rat urines that may influence COM crystalliza-
tion have been changed as a consequence of the CID. 
(2) The mechanisms that controls crystal growth and ag-
glomeration might be different. Because of the in-
creased number of particles, the possibility that the pre-
sents results are due to a second nucleation induced by 
the addition of the urines cannot be excluded. The ad-
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vantage and weakness of the Counter model used in our 
laboratory have been recently discussed [ 47]. 
R.L. Hackett: What is the definition of nephro-calci-
nosis? Please explain the difference between it and crys-
tallization and crystal localization. 
Authors: Nephrocalcinosis is defined as crystal deposi-
tion outside the calyx and the tubular system, i.e., in the 
cortical and/or in the medullary parenchyma. 
R.L. Hackett: In Materials and Methods, the text im-
plies as though you checked crystalluria on urines that 
had been continuously iced throughout the collection pe-
riod. If so, what do the authors conclude about the 
crystals that were salted out in this process? 
Authors: The wish to preserve the activities of urinary 
enzymes and to prevent bacterial growth left us no other 
choice than to collect the urines on ice. Although we 
cannot exclude the possibility that the low temperature 
salted out CaOx monohydrate and dihydrate crystals, it 
must be realized that, in all likelihood, the urinary 
inhibitors of crystal growth and agglomeration are still 
effective at this low temperature. 
R.L. Hackett: I am curious to know whether or not 
you provided the animals with a "mush" form of rat 
chow. Providing mush is important in regulating the an-
imals dietary intake as well as limiting the contamination 
of the urine collectors. Also, it does not appear that the 
animals were "pair fed". Was the intake of EG moni-
tored? In our experiments , some animals, if left to 
drink ad libitum, will take excessive quantities of this 
fluid . It al so appears that there were no control animals 
that were intubated, stressful and invasive procedure. 
Would the authors enter into more detail of these points? 
J.P. Kavanagh: Ideally each experimental group of rats 
would have a relevant control group, randomly selected 
from aged and weighed animals. They should be studied 
at the same time and housed under the same conditions. 
It is not clear if this was always the case. Did the 
different groups differ in their consumption of EG-con-
taining water? Did the control rats receive placebo 
intubations? 
Authors: All rats were of the same age and weight. 
They were housed under the same conditions and for the 
same period of time. The rats were fed standard chow 
in form of pellets. The rats were individually housed, 
the EG intake was not followed. We observed that all 
rats, fed either the standard chow or the CID of vitamin 
D3 and O. 5 % EG, consumed on the average 40 ml water 
each day. In pilot experiments, we found that the rats 
drank excessive amounts of EG containing water, if we 
increased the EG concentration in the drinking water to 
0.75%, 1.0, or 1.5%. Hence, in this series of dietary 
R. de Water et al. 
experiments, the daily ration of drinking water was 
limited to 40 ml. The control rats did not receive 
placebo intubations. As far as we could verify, the ani-
mals tolerated the intubations were very well. It ap-
peared essential, however, that the intubations were 
performed by a trained biotechnician. 
R.L. Hackett: In our laboratory, we have found that 
kidney/papilla oxalate content needs to be normalized by 
either protein or by weight. For one reason, since the 
papilla tissue is so small, alterations of its values are 
often masked. We find that the kidneys of these animals 
often become enlarged as well and that lyophilization be-
fore digestion is useful in determining true alterations in 
oxalate content. We have found that expressing [Ox]/ 
kidney is not necessarily useful information. Would you 
like to comment on this point? 
Authors: Indeed, biochemical determinations are nor-
mally related to the amount of protein. There are two 
reasons why we abandoned this approach. First, the ox-
alate determinations were performed on kidney digests, 
produced by proteinase K treatment. Protein determina-
tions on such digests may not be reliable. Secondly, in 
the kidney crystal deposition gives rise to an enlarge-
ment of the interstitium, predominantly caused by an in-
crease of the number of interstitial cells and by an in-
crease of the interstitial matrix. Thus, it is likely that 
the amount of kidney protein is higher, if the number of 
interstitial crystals is increased. Both drawbacks are 
avoided if the oxalate determinations are related per 
whole kidney . We also agree that the excision of papil-
lary tissue is inaccurate. However, one must realize 
that, in the papilla, most of the oxalate is present in 
small stones. This means that in the papilla, the amount 
of oxalate varies more according to the absence or pres-
ence of small stones than to the changes in the amount 
of protein. Thus, the distribution of oxalate over the 
papilla and the remainder of the kidney seems to be less 
dependent on the protein ratios of both compartments. 
J.P. Kavanagh: It is not clear to me how many rats 
were used in the different experiments. It is also not 
clear what the control data represent in the Figures 3, 5, 
6, and 7. 
Authors: In total, 33 rats were used. Twenty four rats 
were used in the time course study, in which the calcium 
and oxalate response of Wistar and SD rats was com-
pared (Table 1). For the EG concentration studies, nine 
rats were used, three for each group (group I-III). 
Since, at day 0, all rats were fed the standard chow, in 
this dietary study, the experimental rats of day O were 
the control group (open bars in Figs. 3, 4, 5, 6 and 7). 
J.P. Kavanagh: To say that in Figure 1, during the 
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first 3 weeks, all rats showed reduced calcium excretion 
does not fit with the finding in this figure that two 
samples during this time period showed calcium excre-
tion within the range quoted for the controls. What was 
the oxalate range of the control animals? Were there 
any real changes in excretory patterns over time 
observed for the controls? 
Authors: As shown in Table 2, the Wistar and SD rats, 
fed the standard chow, showed no prominent differences 
in calcium excretion. These data have a mean of 18.5 
± 8.6 µmol/24 h (range: 7 .3-39.1 µmol/24 h). If in 
this experiment, for each point of time all data of the 
CID-fed Wistar and SD rats are pooled a lower calcium 
excretion is calculated at day 6 and 14, although not yet 
significant in the Wilcoxon matched-pairs test (p < 
0.07). 
E.J. Nouwen: Does the observation that the caicium 
excretion is reduced after CID indicate that vitamin Dr 
stimulated calcium uptake in the experimental rats might 
be lower than the normal calcium uptake in the control 
rats? Also, although the authors mention that the de-
crease in body weight (which might better be accurately 
specified) was especially evident in the animals treated 
with the highest EG dose of 1 and 1.5 % , this appears 
not to be correlated with the urinary calcium excretion 
data presented in the Figures IA and 3A, which are sim-
ilar for all experimental rats. Has a possible 
interference of oxalate ions with the determination of 
calcium been investigated methodologically? 
Authors : In experimental rat nephrolithiasis, the urine 
is supersaturated with calcium and oxalate. Precipitation 
of the CaOx crystals decreases the urinary concentration 
of free calcium and oxalate. This decrease is most obvi-
ously noticed in the calcium concentration, since, com-
pared with oxalate, the urinary concentration of this ion 
is low. We performed also a control experiment in 
which we investigated the effect of vitamin D3. Com-
pared with 0.5 % EG alone, we found that vitamin D3 + 
0.5 % EG does not enhance the calcium excretion (Table 
4). Apparently, the administration of vitamin D3, which 
has been reported to enhance the intestinal absorption of 
calcium, did not compensate for this decrease in urinary 
calcium. 
H.G. Tiselius: To further emphasize the importance of 
the present findings, I would like to read exactly what 
conclusions the authors have drawn from these experi-
ments with respect to the usefulness of this animal mod-
el. The impression I get is that, in addition to the un-
physiologic concentrations of oxalate necessary for crys-
tallization, there appears to be toxic effect on the kidney 
that are so pronounced that the model seems useless in 
studying stone formation. Do you agree? 
Experimental rat nephrolithiasis 
Table 4. The effect of vitamin D3 on the urinary excretion of calcium and oxalate in Wistar rats. In this study rats 
were fed a CID of 1.5 % EG or a CID of vitamin D3 + 1.5 % EG . At day O the rats were fed the standard diet. Data 
are expressed as µ.mol/24 h (mean ± s.d.; n=3). 
Experimental day 
l.5%EG 
Oxalate excretion 
Calcium excretion 
0 6 
7.7 ± 1.3 103.7 ± 24.9 
26.7 ± 14.9 10.0 ± 3.3 
Vitamin D3 + 1.5% EG 
Oxalate excretion 8.7 ± 0.5 100.3 ± 42.7 
Calcium excretion 23.7 ± 20.8 9.3 ± 2.9 
Authors: We agree that the rat, as model for nephro-
lithiasis, is based upon the creation of a rather unphysio-
logically high concentrations of oxalate in urine. How-
ever, in an accompanying paper [13), we show that high 
oxalate concentration, on itself, does not lead to any 
kidney damage. Specifically, it was found that the re-
tained crystals give rise to morphological and cytochemi-
cal changes, including glomerular damage, enlargement 
of the interstitium, tubular dilatation, increase of mitotic 
activity of interstitial and tubular cells, and changes in 
the staining pattern of Tamm-Horsfall protein . As such, 
this rat model is suitable to study, in vivo, the interac-
tion of the retained crystals with the surrounding inter-
stitial and tubular cells. In the renal interstitium of rats, 
four cell types have been described [48), and in prelimi-
nary experiments, we found that nearly all interstitial 
crystals are surrounded by macrophages [13). There-
fore, the present rat model is preeminently suitable to 
study the interaction of interstitial cells, including 
macrophages, lymphocytes, dendritic cells and fibro-
blasts, with interstitial and papillary crystals and to study 
the contribution of these cells to kidney damage and 
regeneration. 
4 21 28 42 
34.7 ± 34.0 115.3 ± 26.7 114.7 ± 21.9 98.0 ± 36.1 
6.7 ± 2.4 2.3 ± 0.5 8.7 ± 0.9 8.3 ± 0.5 
0.0 ± 41.8 85.3 ± 21.0 62.7 ± 6.9 
8.0 ± 4.6 13.0 ± 11.3 7.7 ± 1.3 
77.7 ± 11.9 
11.3 ± 2.1 
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